欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/V/0114/001
药品名称Borrelym 3, Merilym 3, Trilyme suspension for injection for dogs
活性成分
    • borrelia afzelii 1.0 RP
    • borrelia burgdorferi 1.0 RP
    • borrelia garinii 1.0 RP
剂型Suspension for injection
上市许可持有人Bioveta,a.s. Komenského 212 683 23 Ivanovice na Hané Czech Republic
参考成员国 - 产品名称Czechia (CZ)
Borrelym 3, injekční suspenze pro psy
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Portugal (PT)
    • Sweden (SE)
    • Norway (NO)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • United Kingdom (Northern Ireland) (XI)
许可日期2012/12/20
最近更新日期2024/07/03
药物ATC编码
    • QI07AB04 borrelia
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase